SCHEMBL18201295

SCHEMBL18201295

c1ccc(-c2ccc(-c3nc(-c4ccccc4)cc(-c4cnc(-c5nc6ccccc6c6c5ccc5ccccc56)nc4)n3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.44
LMNA P02545 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
RECQL P46063 1/20 0.44
PTGES O14684 1/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
NTSR1 P30989 1/20 0.40
KDM4E B2RXH2 2/20 0.40
DHODH Q02127 3/20 0.40
MAPK10 P53779 1/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
MTOR P42345 1/20 0.37
PIK3CG P48736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18201268 1.00 MAPT (0.44) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL18201300 1.00 MAPT (0.44) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL18200670 0.98 MAPT (0.46) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL18200711 0.94 MAPT (0.45) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL18200700 0.89 DHODH (0.41) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL18200707 0.89 DHODH (0.41) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL18200692 0.89 DHODH (0.41) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL18346953 0.89 MEN1 (0.47) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL18200523 0.89 MEN1 (0.47) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL18200421 0.89 MEN1 (0.47) MAPTLMNANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MAPT 1937/4885LMNA 3373/4885NPC1 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.